ETHICAL CONSIDERATIONS OF THE USE OF INVESTIGATIONAL NEW DRUGS DURING THE GULF WAR
Electronic Theses and Dissertations
Item Files
Item Details
- abstract
- At the onset of the Gulf War in 1992, the threat of chemical and biological weapons prompted the Department of Defense to seek a waiver from the Food and Drug Administration to use the investigational new drugs pyridostigmine bromide and botulism vaccine without first obtaining consent from those servicemen and women who would receive the drugs. The waiver was granted and came in the form of the Interim Rule, which permitted the use of investigational new drugs when consent could not be obtained because of "non-feasibility" and the nature of the military mission. The Interim Rule restricted the soldiers' rights to informed consent, but was it justified?
- subject
- Gulf War
- Interim Rule
- Investigational New Drugs
- pyridostigmine bromide
- contributor
- Hall, Mark (committee chair)
- Hyde, Michael (committee member)
- Coughlin, Christine (committee member)
- date
- 2011-09-08T08:35:58Z (accessioned)
- 2011-09-08T08:35:58Z (available)
- 2011 (issued)
- degree
- Bioethics (discipline)
- identifier
- http://hdl.handle.net/10339/36150 (uri)
- language
- en (iso)
- publisher
- Wake Forest University
- title
- ETHICAL CONSIDERATIONS OF THE USE OF INVESTIGATIONAL NEW DRUGS DURING THE GULF WAR
- type
- Thesis